PDI announced it has generated data showing that its Super Sani-Cloth wipes are effective against SARS-CoV-2, the virus that causes COVID-19.
This is one of several of the company’s hospital-grade disinfecting products being tested for efficacy against SARS-CoV-2 for submission to the EPA for approval. Testing of the additional disinfecting products is still underway and results are expected in the upcoming months.
According to the data, the wipes demonstrated a 3-log reduction against the virus. The wipes were tested in compliance with “Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing,” the EPA’s threshold for deeming a disinfectant effective.
Microbac Laboratories, Inc., an independent laboratory that performs environmental, food, and life science testing for businesses, performed the efficacy testing.
Other PDI products included on EPA List N are currently being tested by Microbac and results are expected in the coming months.